Cookie Consent by Free Privacy Policy Generator
Search
Close this search box.

Cleveland Clinic and IBM Unveil First Quantum Computer Dedicated to Healthcare Research

IBM Cleveland Clinic

Insider Brief

  • Cleveland Clinic and IBM officially unveiled the first onsite private sector IBM-managed quantum computer in the United States.
  • The Cleveland Clinic-IBM Discovery Accelerator is working on projects that leverage the latest in quantum computing, AI and hybrid cloud for biomedical research.
  • Critical Quote: “This technology holds tremendous promise in revolutionizing healthcare and expediting progress toward new cares, cures and solutions for our patients. Quantum and other advanced computing technologies will help researchers tackle historic scientific bottlenecks and potentially find new treatments for patients with diseases like cancer, Alzheimer’s and diabetes.”–Tom Mihaljevic, M.D., Cleveland Clinic CEO and President and Morton L. Mandel CEO Chair.

PRESS RELEASE —

Cleveland Clinic and IBM officially unveiled the first deployment of an onsite private sector IBM-managed quantum computer in the United States. The IBM Quantum System One installed at Cleveland Clinic will be the first quantum computer in the world uniquely dedicated to healthcare research with an aim to help Cleveland Clinic accelerate biomedical discoveries.

The unveiling comes as a key milestone in Cleveland Clinic’s and IBM’s 10-year Discovery Accelerator partnership, announced in 2021, which is focused on advancing the pace of biomedical research through the use of high-performance computing, artificial intelligence and quantum computing. The system was unveiled at a formal event today featuring leaders from IBM and Cleveland Clinic, Mayor of Cleveland Justin Bibb, Lt. Governor of Ohio Jon Husted and Congresswoman Shontel Brown (OH-11).

Quantum computing is a rapidly emerging technology that harnesses the laws of quantum mechanics to solve problems that today’s most powerful supercomputers cannot practically solve and never will. The ability to tap into these new computational spaces could help researchers discover new medicines and treatments more quickly.

Responsive Image

“This is a pivotal milestone in our innovative partnership with IBM, as we explore new ways to apply the power of quantum computing to healthcare,” said Tom Mihaljevic, M.D., Cleveland Clinic CEO and President and Morton L. Mandel CEO Chair. “This technology holds tremendous promise in revolutionizing healthcare and expediting progress toward new cares, cures and solutions for our patients. Quantum and other advanced computing technologies will help researchers tackle historic scientific bottlenecks and potentially find new treatments for patients with diseases like cancer, Alzheimer’s and diabetes.”

In addition to quantum computing, the Cleveland Clinic-IBM Discovery Accelerator draws upon a variety of IBM’s latest advancements in computing technologies, including high performance computing via the hybrid cloud and artificial intelligence. Researchers from both organizations are collaborating closely on a robust portfolio of projects with these advanced technologies to generate and analyze massive amounts of data to enhance research.

The Cleveland Clinic-IBM Discovery Accelerator has generated multiple projects that leverage the latest in quantum computing, AI and hybrid cloud to help expedite discoveries in biomedical research. These include:

  • Development of quantum computing pipelines to screen and optimize drugs targeted to specific proteins;
  • Improvement of a quantum-enhanced prediction model for cardiovascular risk following non-cardiac surgery; and
  • Application of artificial intelligence to search genome sequencing findings and large drug-target databases to find effective, existing drugs that could help patients with Alzheimer’s and other diseases.

The Discovery Accelerator also serves as the technology foundation for Cleveland Clinic’s Global Center for Pathogen & Human Health Research, part of the Cleveland Innovation District. The center, supported by a $500 million investment from the State of Ohio, Jobs Ohio and Cleveland Clinic, brings together a team focused on studying, preparing and protecting against emerging pathogens and virus-related diseases. Through the Discovery Accelerator, researchers are leveraging advanced computational technology to expedite critical research into treatments and vaccines.

A significant part of the collaboration is a focus on educating the workforce of the future and creating jobs to grow the economy. An innovative educational curriculum is being designed for participants from high school to the professional level, offering training and certification programs in data science, machine learning and quantum computing to build the skilled workforce needed for cutting-edge computational research of the future.

Additionally, the two organizations are hosting research symposia, seminars and workshops intended for academia, industry, government and the public with a goal of building a critical mass of computing specialists in Cleveland.

If you found this article to be informative, you can explore more current quantum news here, exclusives, interviews, and podcasts.

The Future of Materials Discovery: Reducing R&D Costs significantly with GenMat’s AI and Machine Learning Tools

When: July 13, 2023 at 11:30am

What: GenMat Webinar

Picture of Jake Vikoren

Jake Vikoren

Company Speaker

Picture of Deep Prasad

Deep Prasad

Company Speaker

Picture of Araceli Venegas

Araceli Venegas

Company Speaker

Matt Swayne

With a several-decades long background in journalism and communications, Matt Swayne has worked as a science communicator for an R1 university for more than 12 years, specializing in translating high tech and deep tech for the general audience. He has served as a writer, editor and analyst at The Quantum Insider since its inception. In addition to his service as a science communicator, Matt also develops courses to improve the media and communications skills of scientists and has taught courses. [email protected]

Share this article:

Keep track of everything going on in the Quantum Technology Market.

In one place.

Join Our Newsletter